St Mark's Hospital, Harrow, Middlesex, UK.
Colorectal Dis. 2011 Sep;13(9):e293-6. doi: 10.1111/j.1463-1318.2011.02684.x.
Anal pain may occur in the absence of demonstrable anal pathology. Spasm of the sphincter muscles has been suggested as a cause in some patients. We aimed to assess the effectiveness of injection of botulinum toxin in treating this condition.
Patients who had injection of botulinum toxin over a 3-year period were identified retrospectively. Patients were excluded if anal fissure or other organic pathology was found to account for their symptoms on examination under anaesthetic. Long-term outcome was assessed at a minimum 3-year post-procedure telephone follow up.
Fourteen (eight male) patients were identified, of median age 50 years. Botulinum toxin (20-200 u) was injected into the internal sphincter. Seven of the 14 patients reported significant improvement in symptoms at 3 months. Seven were available for a structured telephone review at a median of 59 (42-68) months. The four patients who had benefited from the injection had remained asymptomatic.
Injection of botulinum toxin into the internal anal sphincter has a role in alleviating symptoms in a small proportion of patients with functional anal pain.
在没有明显肛门病理的情况下,可能会出现肛门疼痛。一些患者认为括约肌痉挛是其病因。我们旨在评估肉毒杆菌毒素注射治疗这种疾病的效果。
回顾性地确定了在 3 年内接受肉毒杆菌毒素注射的患者。如果在麻醉下检查发现肛门裂或其他器质性病变是导致其症状的原因,则将患者排除在外。在程序后至少 3 年的电话随访中评估长期结果。
确定了 14 名(8 名男性)患者,中位年龄为 50 岁。肉毒杆菌毒素(20-200u)被注射到内括约肌中。14 名患者中有 7 名在 3 个月时报告症状显著改善。在中位数为 59(42-68)个月时,有 7 名患者可进行结构化电话复查。从注射中受益的 4 名患者一直无症状。
将肉毒杆菌毒素注射到内肛门括约肌中在一小部分功能性肛门疼痛患者中可以缓解症状。